Zyleris PharmaTech

Zyleris Pharma Tech

Pharmaceuticals, 11 N Skokie Hwy, Lake Bluff, Illinois, 60044, United States, 11-50 Employees

zyleris.com

  • LinkedIn

phone no Phone Number: +18*********

Who is ZYLERIS PHARMATECH

Zyleris PharmaTech offers topical formulation development and screening service using our first-in-class high-throughput Franz Cell technology. The proprietary technology was developed ba...

Read More

map
  • 11 N Skokie Hwy, Lake Bluff, Illinois, 60044, United States Headquarters: 11 N Skokie Hwy, Lake Bluff, Illinois, 60044, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 5169

checked-icon Does something look wrong? Fix it. | View contact records from ZYLERIS PHARMATECH

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Zyleris PharmaTech

Answer: Zyleris PharmaTech's headquarters are located at 11 N Skokie Hwy, Lake Bluff, Illinois, 60044, United States

Answer: Zyleris PharmaTech's phone number is +18*********

Answer: Zyleris PharmaTech's official website is https://zyleris.com

Answer: Zyleris PharmaTech's revenue is Under $1 Million

Answer: Zyleris PharmaTech's SIC: 5169

Answer: Zyleris PharmaTech has 11-50 employees

Answer: Zyleris PharmaTech is in Pharmaceuticals

Answer: Zyleris PharmaTech contact info: Phone number: +18********* Website: https://zyleris.com

Answer: Zyleris PharmaTech offers topical formulation development and screening service using our first-in-class high-throughput Franz Cell technology. The proprietary technology was developed based on industry standard Franz Cell principle. It offers best of both worlds - speed and cost efficiency associated with high-throughput experimentation, and data compatibility with the standard Franz Cell technology. Services provided: 1. High-throughput skin absorption and penetration screening (IVPT). 2. High-throughput in vitro release testing (IVRT). 3. Topical formulation development and reverse engineering. 4. Novel topical drug delivery technologies. In addition, Zyleris maintains active internal R&D programs. Up to date, Zyleris has developed two patent-pending technologies. One is a drug-release enhancement technology in topical formulations. The other is an IVRT method technology.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access